Amy Jo Sterling

Array ( [id] => 6467599 [patent_doc_number] => 20020150993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/116378 [patent_app_country] => US [patent_app_date] => 2002-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23103 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150993.pdf [firstpage_image] =>[orig_patent_app_number] => 10116378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 679157 [patent_doc_number] => 07083793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Tango 243 polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/107857 [patent_app_country] => US [patent_app_date] => 2002-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 41914 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083793.pdf [firstpage_image] =>[orig_patent_app_number] => 10107857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 644741 [patent_doc_number] => 07118752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I' [patent_app_type] => utility [patent_app_number] => 10/100492 [patent_app_country] => US [patent_app_date] => 2002-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 55 [patent_no_of_words] => 10081 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/118/07118752.pdf [firstpage_image] =>[orig_patent_app_number] => 10100492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323747 [patent_doc_number] => 20020197232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Methods for using the obese gene and its gene product to stimulate hematopoietic development' [patent_app_type] => new [patent_app_number] => 10/095929 [patent_app_country] => US [patent_app_date] => 2002-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15587 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20020197232.pdf [firstpage_image] =>[orig_patent_app_number] => 10095929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 633850 [patent_doc_number] => 07128905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Method of treating graft versus host disease by administration of a Fas antagonist' [patent_app_type] => utility [patent_app_number] => 10/084139 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16184 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/128/07128905.pdf [firstpage_image] =>[orig_patent_app_number] => 10084139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 560645 [patent_doc_number] => 07157557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Increased recovery of active proteins' [patent_app_type] => utility [patent_app_number] => 10/080471 [patent_app_country] => US [patent_app_date] => 2002-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 10659 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157557.pdf [firstpage_image] =>[orig_patent_app_number] => 10080471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1049950 [patent_doc_number] => 06861227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-01 [patent_title] => 'Antibodies to cytokine receptor common gamma chain like' [patent_app_type] => utility [patent_app_number] => 10/078059 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 129153 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/861/06861227.pdf [firstpage_image] =>[orig_patent_app_number] => 10078059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851467 [patent_doc_number] => 20030143670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'DNA encoding SNORF44 receptor' [patent_app_type] => new [patent_app_number] => 10/080263 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22549 [patent_no_of_claims] => 145 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143670.pdf [firstpage_image] =>[orig_patent_app_number] => 10080263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6406313 [patent_doc_number] => 20020182676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexia' [patent_app_type] => new [patent_app_number] => 10/079625 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 48522 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182676.pdf [firstpage_image] =>[orig_patent_app_number] => 10079625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567039 [patent_doc_number] => 20020165127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Methods for treating insulin resistance and identifying patients at risk for the disease' [patent_app_type] => new [patent_app_number] => 10/079597 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5304 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165127.pdf [firstpage_image] =>[orig_patent_app_number] => 10079597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 797817 [patent_doc_number] => 07427403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-23 [patent_title] => 'Methods for inhibiting lymphotoxin β receptor signalling' [patent_app_type] => utility [patent_app_number] => 10/077406 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 17918 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427403.pdf [firstpage_image] =>[orig_patent_app_number] => 10077406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660144 [patent_doc_number] => 20030134788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Human tumor necrosis factor receptor TR16' [patent_app_type] => new [patent_app_number] => 10/073333 [patent_app_country] => US [patent_app_date] => 2002-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 132416 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134788.pdf [firstpage_image] =>[orig_patent_app_number] => 10073333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033074 [patent_doc_number] => 20050031583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Uses of opg to modulate immune responses' [patent_app_type] => utility [patent_app_number] => 10/129595 [patent_app_country] => US [patent_app_date] => 2002-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26866 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20050031583.pdf [firstpage_image] =>[orig_patent_app_number] => 10129595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861093 [patent_doc_number] => 20030092101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Human tumor necrosis factor receptors TR13 and TR14' [patent_app_type] => new [patent_app_number] => 10/046433 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 192890 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092101.pdf [firstpage_image] =>[orig_patent_app_number] => 10046433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476313 [patent_doc_number] => 20020151697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'DNA encoding orphan SNORF68 receptor' [patent_app_type] => new [patent_app_number] => 10/050726 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6488 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151697.pdf [firstpage_image] =>[orig_patent_app_number] => 10050726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 990553 [patent_doc_number] => 06919078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-19 [patent_title] => 'Antibodies to human tumor necrosis factor receptor TR9' [patent_app_type] => utility [patent_app_number] => 10/041574 [patent_app_country] => US [patent_app_date] => 2002-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 87009 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/919/06919078.pdf [firstpage_image] =>[orig_patent_app_number] => 10041574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658603 [patent_doc_number] => 20030078406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Methods and compositions for DRM, a secreted protein with cell growth inhibiting activity' [patent_app_type] => new [patent_app_number] => 10/033717 [patent_app_country] => US [patent_app_date] => 2001-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24205 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078406.pdf [firstpage_image] =>[orig_patent_app_number] => 10033717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828345 [patent_doc_number] => 20020068300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Method for the detection of compounds that modulate the effects of the obese protein' [patent_app_type] => new [patent_app_number] => 10/036956 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2465 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068300.pdf [firstpage_image] =>[orig_patent_app_number] => 10036956 [rel_patent_id] =>[rel_patent_doc_number] =>)